Results 221 to 230 of about 2,891,280 (363)

Motivations for sustained use of modern contraceptives in a peri-urban area: An analytical cross-sectional study. [PDF]

open access: yesPLoS One
Amponsah-Tabi S   +9 more
europepmc   +1 more source

Safer Access With Fewer Transfusions: Revisiting Platelet Thresholds in Pediatric Central Venous Catheterization

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Background Central venous catheters (CVCs) are essential in pediatric hematology‐oncology, for the administration of chemotherapy and supportive therapy. Thrombocytopenia increases the risk of bleeding and current guidelines recommend prophylactic platelet transfusions below 40–50 × 109/L, though evidence is limited and transfusions entail ...
Alessandro Raffaele   +8 more
wiley   +1 more source

Knowledge, attitudes, practice and factors associated with the prevalence of modern contraceptives use among women from historically marginalized community in Rwanda: a cross-sectional study. [PDF]

open access: yesBMC Public Health
Hitayezu JBH   +9 more
europepmc   +1 more source

The role of gender inequality and health expenditure on the coverage of demand for family planning satisfied by modern contraceptives: a multilevel analysis of cross-sectional studies in 14 LAC countries. [PDF]

open access: yesLancet Reg Health Am, 2023
Moreira LR   +11 more
europepmc   +1 more source

Philadelphia chromosome‐positive acute lymphoblastic leukaemia in children and adolescents: A changing treatment landscape and a methodological challenge

open access: yes
British Journal of Haematology, EarlyView.
Adriana Balduzzi   +19 more
wiley   +1 more source

Improvements in Real‐World Survival in the Setting of a Recent Paradigm Shift in Acute Myeloid Leukemia Treatment

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Therapeutic options for newly diagnosed (ND) acute myeloid leukemia (AML) have increased in recent years, leading to a shift in the treatment paradigm from conventional, intensive chemotherapy toward targeted and less intensive therapy. Since 2017, there has been a surge in FDA approvals for novel therapies, including small molecule inhibitors
Thuy N. Ho   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy